[The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study)].

I N Samartsev S A Zhivolupov J S Butakova M S Parshin

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)

43.3% of patients with chronic cerebrovascular disease and certain predictors develop long-COVID. Aceclofenac and vinpocetine are effective in relieving a number of symptoms of long-COVID, which requires further study.

Keyphrases

coronavirus disease
sars cov
systematic review
randomized controlled trial
open label
physical activity
depressive symptoms
double blind